ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 133072 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 133072; 2) Community: the network communities that were significantly associated with the response to NSC 133072; 3) Molecule: the relationships between components within communities and NSC 133072; 4) MDR: the compounds that were significantly associated with the NSC 133072.

NSC Compound Enrichment Correlation
NSC 376739 5,12-Naphthacenedione, 10-[(2,6-dideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.00970780973624031 0.3134045
NSC 382034 2,4-Pyrimidinediamine, 6-ethyl-5-[4-(methylamino)- 3-nitrophenyl]- 0.00970780973624031 0.60863713
NSC 604586 2-Butenamide, N-(4-chlorophenyl)-4,4,4-trichloro- 0.00970780973624031 0.094684161
NSC 627506 Null 0.00970780973624031 0.2768897
NSC 633268 Null 0.00970780973624031 0.3942295
NSC 633273 ANTINEOPLASTIC-633273 0.00970780973624031 0.32949668
NSC 637126 Null 0.00970780973624031 0.44685388
NSC 638635 Propyl-1-aminium, 3-[3,5-bis(phenylmethylene)-4-oxo- piperidin-1-yl]-3-oxo-N,N,N-trimethyl-, bromide 0.00970780973624031 0.40195493
NSC 639518 Cyclopentanone, 2-[[4-(benzoyloxy)-3-methoxyphenyl] methylene]-5-[(dimethylamino)methyl]-, hydrochloride 0.00970780973624031 0.24239182
NSC 644919 Null 0.00970780973624031 0.28281345
Total:117  Current:38    [First] [Prev] [Next] [Last]